Matt, Author at European Medical Journal - Page 93 of 212

Suppression of stress-induced enzyme as therapeutic target for liver cancer

EXPRESSION of an enzyme as a stress-response upregulates significant proliferation pathways in the progression of liver cancer, according to a new study…

Alcohol-Producing Gut Bacteria May Damage Liver

NON-ALCOHOLIC fatty liver disease (NAFLD) is characterised by the build-up of fat in the liver, arising from factors other than alcohol…

"The Nordics are a very enabling ecosystem; many stakeholders are travelling in the same direction as us to support VBHC."

Ingeborg R. Borgheim holds a senior leadership position at Takeda and leads the Nordic Region. We spoke to Ingeborg at eyeforpharma, Barcelona…

Determining Antibiotic-Resistant Infections: A novel Approach

THE RISING increase of antimicrobial resistance, accelerated by the inappropriate use of antibiotics, is of growing concern…

Identification of Important Biomarkers Aid Diagnosis of Myasthenia Gravis

MYASTHENIA gravis (MG) is an autoimmune condition for which diagnosis is notably difficult as the symptoms tend to imitate those of other conditions…

Novel, Bone-Like Particles in Bone Marrow Blood Vessels

IDENTIFICATION of bone-like particles in the blood vessels of bone marrow could serve as an important diagnostic tool for bone marrow blood vessel…

A Smart Artificial Hand for Amputees: The Solution to Neuroprosthetics?

A NEW STUDY conducted at the Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland, showcases the importance of interdisciplinary research…

The IVF Shopping List: To Tick or Not to Tick

The field of reproductive medicine is recognised for its rapid innovations and advanced technologies, but also for its connection with lucrative medical…

Variability of Biologics and its Impact on Biosimilar Development

Biologic drugs are transforming treatment of other hard-to-treat diseases beyond cancer, including multiple sclerosis, heart disease, asthma, and…

Moderate Psoriatic Arthritis and Perspectives from Phosphodiesterase-4 Inhibition

Dr Queiro-Silva opened the session by proposing a definition of the moderate-severity PsA patient: patients associated with a limited number of affected…